CHPT vs DMAC · rev $417.1M vs $157.4M cap
ChargePoint Holdings Inc (CHPT) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
ChargePoint Holdings Inc (CHPT) is a specialty retail company listed on NYSE.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported CHPT revenue for 2025-01-31 was $417.1M. Net income was -$277.1M. Revenue was down 17.7% from 2024-01-31 to 2025-01-31. CHPT currently screens at market cap $199.2M.
DMAC does not have a complete income-statement cache yet.
CHPT currently screens at market cap $199.2M. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the CHPT and DMAC stock pages for the full models.
Not investment advice.